Relationship between knowledge levels of men about prostate cancer screenings and their health literacy
Abstract
Purpose: Prostate cancer is one of the cancer types most frequently causing death throughout the world. Early diagnosis of prostate cancer is important.
This study was directed towards examining the relation between knowledge levels of men aged over 40 about prostate cancer screenings and their health literacy.
Materials and Methods: The study has a descriptive and cross-sectional design and included 501 men selected through proportional cluster sampling. Data were collected with Socio-Demographic Features Form, the Knowledge about Prostate Cancer Screening Questionnaire and Health Literacy Survey Questionnaire.
Results: The mean score for the Knowledge about Prostate Cancer Screening Questionnaire was 3.85±2.05 and the mean score for Health Literacy Survey Questionnaire was 80.87±16.03. There was a significant, positive and moderate relation between the mean score for the Knowledge about Prostate Cancer Screening Questionnaire and that for Health Literacy Survey Questionnaire. The mean score for Health Literacy Survey Questionnaire accounted for 48% of the variance in the scores for the Knowledge about Prostate Cancer Screening Questionnaire.
Conclusion: Knowledge levels of the participants about prostate cancer screenings were affected by their health literacy levels.
Kaynakça
- 1. IARC. (2018). Retrieved from http://gco.iarc.fr/today/home. (accessed November 2018).
- 2. Turkey Republic Health Ministry. (2015). Retrieved from http://kanser.gov.tr. (accessed November 2015).
- 3. IARC. (2012). Retrieved from http://globocan.iarc.fr. (accessed November 2015).
- 4. Europe PMC Funders Group (2015). The Global Burden of Cancer 2013. JAMA Oncoogyl,(4): 505-527. doi: 10.1001/jamaoncol.2015.0735.
- 5. American Cancer Society 2018. Retrieved from https://www.cancer.org/cancer/prostate-cancer.html. (accessed November 2018).
- 6. Schroder FH. Landmarks in prostate cancer screening. BJU International. 2014; 110(1): 3-7. doi:10.1111/j.1464-410X.2012.011428.x.
- 7. Sandblom G, Varenhorst E, Lofman O, Roselld J, Carlssoneet P. Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial inSweden. European Urology. 2004;46(6):717–23. doi:10.1016/j.eururo.2004.08.011.
- 8. Ilic D, O’Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane systematic review. BJU International. 2011; 107(6): 882-91. doi:10.1111/j.1464410X.2010.10032.x.
- 9. Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schönitzer D, … Boyle P. Prostate cancer mortality after introduction of prostate-specifi c antigen mass screening in the Federal State of Tyrol, Austria. Urology. 2001; 58: 417-24. doi:10.1016/S0090-4295(01)01264-X.
- 10. Labrie F, Candas B, Cusan L, Gomez JG, Bélanger A, Brousseau G, Chevrette E, Lévesque J. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate. 2004; 59:311- 318. doi:10.1002/pros.20017.
